Post Market Registry for GORE® TAG® Thoracic Branch Endoprosthesis
NCT ID: NCT06507865
Last Updated: 2025-05-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
200 participants
OBSERVATIONAL
2025-02-20
2031-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Long-term Characterization of GORE® TAG® Conformable Thoracic Stent Graft With ACTIVE CONTROL System Performance
NCT06658730
Feasibility Study for GORE® TAG® Thoracic Branch Endoprosthesis to Treat Proximal Descending Thoracic Aortic Aneurysms
NCT02021812
Evaluation of the GORE TAG Thoracic Endoprosthesis in the Treatment of Aneurysms
NCT00590759
GORE® TAG® Thoracic Endoprosthesis French Mandatory Registry
NCT02266342
GORE TAG® Thoracic Endoprosthesis - 45 mm for the Treatment of Aneurysms of the Descending Thoracic Aorta
NCT00608829
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants will be asked to return for regular scheduled visits as requested by their surgeon. Patients will report any issues they may have regarding the device or surgery to their surgeon/doctor.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
GORE® TAG® Thoracic Branch Endoprosthesis
Patients treated with the TBE Device
GORE® TAG® Thoracic Branch Endoprosthesis
Patients presenting with thoracic vascular disease that may benefit from the placement of TBE device. The target registry population is patients who are treated with TBE at participating sites. TBE treatment is qualified as receiving the TBE aortic component, at a minimum.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
GORE® TAG® Thoracic Branch Endoprosthesis
Patients presenting with thoracic vascular disease that may benefit from the placement of TBE device. The target registry population is patients who are treated with TBE at participating sites. TBE treatment is qualified as receiving the TBE aortic component, at a minimum.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
W.L.Gore & Associates
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medizinische Universität Wien
Vienna, , Austria
Rigshospitalet University Hospital
Copenhagen, , Denmark
Universitätsklinikum Carl Gustav Carus Dresden
Dresden, , Germany
University of Heidelberg
Heidelberg, , Germany
Universitätsklinikum Schleswig-Holstein
Kiel, , Germany
Universitätsklinikum Münster
Münster, , Germany
Evangelismos General Hospital
Athens, , Greece
Laiko General hospital of Athens
Athens, , Greece
Policlinico di Sant'Orsola
Bologna, , Italy
ASST Spedali Civili di Brescia
Brescia, , Italy
IRCCS Ospedale Policlinico San Martino
Genova, , Italy
AOU Padova
Padua, , Italy
Azienda Ospedaliera "G. Brotzu"
Selargius, , Italy
Amsterdam UMC
Amsterdam, , Netherlands
Radboud UMC
Nijmegen, , Netherlands
Complejo Hospitalario Universitario de Vigo
Vigo, , Spain
Hospital Universitario Miguel Servet
Zaragoza, , Spain
Skane University Hospital
Malmo, , Sweden
St Thomas' Hospital
London, , United Kingdom
St Mary's Hospital
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TGR 23-02TB
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.